PDGFRA and gastrointestinal stromal tumor: Since PDGFRA exon 14 mutant GIST is sensitive to imatinib mesylate (Glivec), this oral treatment was started postoperatively because the high risk of recurrence in this patient (high risk of progressive disease according to the Fletcher classification).